title: Therapeutic results of intra-arterial thrombolysis after full-dose intravenous tissue plasminogen activator administration.
abstract: OBJECTIVE
  IV administration of tPA is accepted as a standard treatment for acute cerebral ischemia, but the clinical outcomes cannot be guaranteed in patients who are not recanalized after IV-tPA and in those who are not eligible for IV-tPA. In this study, outcomes from groups of patients treated with additional IA thrombolytic therapy with the use or omission of IV-tPA administration were compared.
  
  
  METHODS
  IA thrombolytic therapy (thrombolytic agents combined with mechanical intervention) was attempted in those patients who were not eligible for IV-tPA and who showed continuous major vessel occlusion after IV-tPA. Sixty-three patients were divided into 2 groups: a tPA group (n = 29, IA thrombolysis after IV-tPA) and a non-tPA group (n = 34, IA thrombolysis without IV-tPA). These groups were subdivided according to match or mismatch DWI/PWI after MR imaging. Treatment results were compared by recanalization rate, clinical outcome, mortality, and ICH rate.
  
  
  RESULTS
  The recanalization rate was 79.3% in the tPA group and 55.9% in the non-tPA group (χ(2) test, P < .05). Subgroup analysis between DWI/PWI mismatch in the tPA group and DWI/PWI mismatch in the non-tPA group also showed no statistical difference in recanalization rate, favorable clinical outcome, and mortality (χ(2) test, P > .05), but the significant ICH rate was high in the tPA group (χ(2) test, P < .05).
  
  
  CONCLUSIONS
  Additional IA thrombolytic treatment after full-dose IV-tPA administration might be an acceptable treatment option for patients with DWI/PWI mismatch.
authors.affiliation: Department of Neurosurgery, St. Mary's Hospital, Uijeongbu, South Korea. yooman@catholic.ac.kr
authors.forename: D-S
authors.initials: DS
authors.lastname: Yoo
authors.forename: Y-D
authors.initials: YD
authors.lastname: Won
authors.forename: P-W
authors.initials: PW
authors.lastname: Huh
authors.forename: H-E
authors.initials: HE
authors.lastname: Shin
authors.forename: K-T
authors.initials: KT
authors.lastname: Kim
authors.forename: S-G
authors.initials: SG
authors.lastname: Kang
authors.forename: S-B
authors.initials: SB
authors.lastname: Lee
authors.forename: K-S
authors.initials: KS
authors.lastname: Cho
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D002545:Brain Ischemia / Q000188:drug therapy* / Q000473:pathology; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D019233:Retreatment; D012189:Retrospective Studies; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D055815:Young Adult
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator
references.citation: Stroke. 1981 Nov-Dec;12(6):723-5
references.pmid: 6272455
references.citation: Stroke. 2002 May;33(5):1437-41
references.pmid: 11988629
references.citation: Stroke. 2005 Oct;36(10):2286-8
references.pmid: 16179581
references.citation: CNS Drugs. 2002;16(4):213-8
references.pmid: 11945105
references.citation: Cerebrovasc Dis. 2004;17(1):13-20
references.pmid: 14530633
references.citation: Lancet Neurol. 2009 Sep;8(9):802-9
references.pmid: 19647488
references.citation: J Vasc Interv Radiol. 2002 Aug;13(8):769-74
references.pmid: 12171979
references.citation: JAMA. 1999 Dec 1;282(21):2003-11
references.pmid: 10591382
references.citation: Stroke. 2007 Oct;38(10):2640-5
references.pmid: 17702961
references.citation: Eur J Radiol. 2003 Apr;46(1):67-78
references.pmid: 12648803
references.citation: Stroke. 2004 Apr;35(4):904-11
references.pmid: 15017018
references.citation: Stroke. 1999 Dec;30(12):2598-605
references.pmid: 10582984
references.citation: Stroke. 2008 Aug;39(8):2249-56
references.pmid: 18535273
references.citation: JAMA. 1995 Oct 4;274(13):1017-25
references.pmid: 7563451
references.citation: Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000514
references.pmid: 15494998
references.citation: Ann Neurol. 1996 Aug;40(2):216-26
references.pmid: 8773603
references.citation: Neuroradiology. 2003 Nov;45(11):755-66
references.pmid: 14557902
references.citation: J Cereb Blood Flow Metab. 1998 Dec;18(12):1298-307
references.pmid: 9850142
references.citation: Acta Neurochir (Wien). 2009 Jan;151(1):21-30
references.pmid: 19096757
references.citation: Stroke. 2000 Jun;31(6):1318-28
references.pmid: 10835451
references.citation: Stroke. 2004 Jan;35(1):109-14
references.pmid: 14671246
references.citation: Ann Neurol. 2006 Nov;60(5):508-17
references.pmid: 17066483
references.citation: Catheter Cardiovasc Interv. 2000 Jan;49(1):113-6
references.pmid: 10627383
references.citation: Stroke. 2007 Jul;38(7):2127-35
references.pmid: 17525387
references.citation: Eur J Neurol. 2006 Dec;13(12):1271-83
references.pmid: 17116208
references.citation: Stroke. 2004 Apr;35(4):876-81
references.pmid: 14988575
references.citation: Cerebrovasc Dis. 2005;20(1):12-7
references.pmid: 15925877
references.citation: Lancet Neurol. 2008 Apr;7(4):299-309
references.pmid: 18296121
references.citation: N Engl J Med. 1995 Dec 14;333(24):1581-7
references.pmid: 7477192
references.citation: Stroke. 2007 Mar;38(3):967-73
references.pmid: 17272772
references.citation: Neurosurgery. 2000 Jun;46(6):1316-24; discussion 1324-5
references.pmid: 10834637
references.citation: J Neurol Neurosurg Psychiatry. 2007 May;78(5):485-91
references.pmid: 17056631
references.citation: Radiology. 2002 May;223(2):361-70
references.pmid: 11997538
references.citation: Neurology. 2001 Nov 13;57(9):1603-10
references.pmid: 11706099
references.citation: Stroke. 2007 May;38(5):1655-711
references.pmid: 17431204
references.citation: Neurosurgery. 2002 Feb;50(2):251-9; discussion 259-60
references.pmid: 11844259
references.citation: Neurosurgery. 2004 Jan;54(1):39-44; discussion 44-6
references.pmid: 14683539